Search results for "chronic pelvic pain"

showing 3 items of 3 documents

Imbalance between sympathetic and sensory innervation in peritoneal endometriosis

2011

To investigate possible mechanisms of pain pathophysiology in patients with peritoneal endometriosis, a clinical study on sensory and sympathetic nerve fibre sprouting in endometriosis was performed. Peritoneal lesions (n= 40) and healthy peritoneum (n= 12) were immunostained and analysed with anti-protein gene product 9.5 (PGP 9.5), anti-substance P (SP) and anti-tyrosine hydroxylase (TH), specific markers for intact nerve fibres, sensory nerve fibres and sympathetic nerve fibres, respectively, to identify the ratio of sympathetic and sensory nerve fibres. In addition, immune cell infiltrates in peritoneal endometriotic lesions were analysed and the nerve growth factor (NGF) and interleuki…

Sensory and sympathetic innervationPathologySympathetic nervous systemSympathetic Nervous SystemInterleukin-1betaEndometriosisSubstance PSubstance PSensory Receptor CellBehavioral Neurosciencechemistry.chemical_compoundNerve FibersGAP-43 ProteinGanglia SpinalNerve Growth FactorAscitic FluidMedicineEndometriosis; Neurotransmitters; Sensory and sympathetic innervationEndometriosiNGFImmunity CellularGanglia SympatheticNeurotransmittersMiddle AgedImmunohistochemistrymedicine.anatomical_structureNerve FiberIL-1βPain generation of endometriosis-related symptomFemaleUbiquitin ThiolesteraseHumanSensory nerveAdultmedicine.medical_specialtySensory Receptor CellsTyrosine 3-MonooxygenaseNeuriteImmunologyEndometriosisYoung AdultImmune cell infiltratePeritoneumInternal medicineHumansNerve Growth FactorsNeurotransmitterCell ProliferationInflammationEndocrine and Autonomic Systemsbusiness.industryStromal Cellmedicine.diseaseSensory Receptor CellsNerve growth factorEndocrinologychemistryLaparoscopyStromal CellsbusinessChronic pelvic painBrain, Behavior, and Immunity
researchProduct

Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpat…

2007

Abstract: Purpose: We evaluated the prevalence and estimated the incidence and risk factors of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy. Materials and Methods: From January to June 2006 patients from 28 Italian urological centers who were between 25 and 50 years old with symptoms of chronic prostatitis/chronic pelvic pain syndrome were consecutively enrolled in this prospective epidemiological case-control study. A total of 152 subjects of similar age, race and area of origin who were investigated for infertile couples but were otherwise healthy served as controls. All subjects provided a medical history and underwent different symptom sco…

AdultMalemedicine.medical_specialtyUrologyProstatitisPelvic PainHospitals SpecialSeverity of Illness IndexSettore MED/24 - UrologiaChronic prostatitis/chronic pelvic pain syndromeRisk Factorsprostate prostatitis quality of life pain life styleInternal medicineSeverity of illnessAmbulatory CarePrevalencemedicineHumansMedical historyRisk factorbusiness.industryIncidenceIncidence (epidemiology)Pelvic painMiddle AgedPrognosismedicine.diseaseProstatitisSurgeryChronic bacterial prostatitisItalyCase-Control StudiesChronic DiseaseQuality of Lifemedicine.symptombusinessJournal of Urology
researchProduct

Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis…

2015

Objectives To evaluate the efficacy of dienogest + estradiol valerate (E2V) and gonadotrophin-releasing hormone analogue (GnRH-a) in reducing recurrence of pain in patients with chronic pelvic pain due to laparoscopically diagnosed and treated endometriosis. Design Multi-center, prospective, randomized study. Setting Three university departments of obstetrics and gynecology in Italy. Population Seventy-eight women who underwent laparoscopic surgery for endometriosis combined with chronic pelvic pain. Methods Post-operative administration of dienogest + E2V for 9 months (group 1) or GnRH-a monthly for 6 months (group 2). Main outcome measures A visual analogue scale was used to test intensit…

Laparoscopic surgerymedicine.medical_treatmentEndometriosischronic pelvic painlaw.inventionGonadotropin-Releasing Hormonechemistry.chemical_compoundEndometriosis;dienogest;GnRH-analogue;pain recurrence;chronic pelvic painRandomized controlled triallawRecurrenceSurveys and QuestionnairesMedicineNandroloneSurveys and QuestionnaireProspective StudiesEndometriosiPain Measurementeducation.field_of_studyEstradiolMedicine (all)Estradiol valerateObstetrics and GynecologyGeneral MedicineMiddle Agedpain recurrenceDrug CombinationsDienogestItalyFemalemedicine.symptommedicine.drugHumanAdultmedicine.medical_specialtyAdolescentVisual analogue scalePopulationEndometriosisPelvic PainHumansPain ManagementEndometriosis GnRH-analogue chronic pelvic pain dienogest pain recurrence.educationGnRH-analoguebusiness.industryPelvic painmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryProspective StudiechemistrydienogestQuality of LifeLaparoscopybusiness
researchProduct